… for SARS-CoV-2 infection, in this review, we introduce the recent progress of therapeutic
vaccines candidates against SARS-CoV-… during the development of vaccines. We also describe …

… To develop preclinical in vitro neutralization and challenge models for a candidate SARS-CoV-2
vaccine, we isolated SARS-CoV-2 strains from bronchoalveolar lavage fluid samples of …

… been exposed to SARS-CoV-2 continues to guide effective vaccine development strategies.
… generating candidate SARS-CoV-2 vaccines and considerations for vaccine development …

… vaccine candidates for SARS-CoV and MERS-CoV enabled the initial step of exploratory …
vaccines could be used. As a result, the first clinical trial of a vaccine candidate for SARS-CoV-…

… the safety evaluation in the development of the vaccine against coronaviruses. Here, we
report the study of an inactivated SARS-CoV-2 vaccine candidate (BBIBP-CorV) and show that …

… efficacy in a murine SARS model by the SARS Accelerated Vaccine Initiative described …
SARS-CoV vaccine and a combination of attenuated adenoviruses, one expressing SARS-CoV …

… vaccine and hepatitis vaccine. Phase I clinical results of the inactivated SARS-CoV vaccine
showed that the candidate vaccine … vaccine was still in the pre-clinical development stage. …

… to SARS-CoV-2 … vaccines and therapeutics. We therefore review current knowledge relevant
to humoral and cellular immunity to SARS-CoV-2 in humans and its application to vaccine …

… -2 S glycoprotein, the RBD is known to be an important vaccine target to elicit humoral …
candidate for the SARS-CoV-1 and MERS-CoV vaccines [34,62]. The nAb against the SARS-CoV-…

… SARS-CoV challenge in vaccinated animals. To optimize expression conditions for scale-up
production of the RBD vaccine candidate, … SARS vaccine candidate for further development. …